Skip to main content
Premium Trial:

Request an Annual Quote

Pairings: Jan 28, 2009

Premium

DxS announced this week the appointment of Jeff Devlin as chief operating officer. Prior to DxS, Devlin was executive VP and executive committee member of Shire Pharmaceuticals, and a partner in Ernst and Young's life science division.

The company noted that Devlin's appointment is one of a number of new promotions and hires planned for 2009. DxS has doubled its workforce size in the last year after opening a new manufacturing space in Manchester, UK, and signing a global distribution deal with Roche Molecular Diagnostics for its TheraScreen diagnostic kits.

Filed under

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.